AliveCor's KardiaMobile six-lead ECG system that works on smartphone platforms. It was cleared in 2019 and includes artificial intelligence algorithms to help identify arrhythmias.
October 31, 2019 — AliveCor, a provider of smartphone based ECG technology and Huami Corp., a provider of biometric, data-driven wearables, announced a global strategic alliance that combines the technologies of each company to deliver a new generation of medical functionality to wearable devices.
“AliveCor’s intelligent, medical grade, heart care platform will be a key component of Huami smart watches and heart trackers going forward. Our new partnership is critical to building these as well as entirely new medical grade services,” said Wang Huang, CEO of Huami.
“AliveCor’s agreement with Huami achieves our corporate goal of delivering AliveCor’s artificial intelligence (AI) driven subscription services and solutions to enterprise customers and consumers worldwide at affordable price points. AliveCor technology allows partners to easily deliver clinically validated, peer-reviewed medical features to their own customers, at scale,” said AliveCor CEO Priya Abani.
The agreement announced today encompasses the licensing of AliveCor technology and an agreement to work together to bring new devices and services to market. The companies expect that the alliance will deliver entirely new ECG form factors to global markets in 2020.
Huami began operations in 2013 and quickly grew, shipping millions of units of smart wearable devices. In 2018, Huami shipped 27.5 million units of smart wearable devices. Huami has one of the largest biometric and activity databases in the global smart wearables industry. Huami’s mobile apps work hand in hand with its smart wearable devices and provide users with a comprehensive view and analysis of their biometric and activity data.
AliveCor offers cardiological care in smartphone based apps that use deep learning. The FDA-cleared KardiaMobile is the most clinically validated personal ECG solution in the world. KardiaMobile provides instant detection of atrial fibrillation, bradycardia, tachycardia, and normal rhythm in an ECG. Kardia is the first AI enabled platform to aid patients and clinicians in the early detection of atrial fibrillation, the most common arrhythmia and one associated with a five times greater risk of stroke. AliveCor’s KardiaPro enterprise platform allows practitioners and institutions to manage chronic heart conditions simply and profitably using KardiaMobile.
For more information: alivecor.com
August 15, 2024 
